nicardipine hydrochloride

Generic: nicardipine hydrochloride

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name nicardipine hydrochloride
Generic Name nicardipine hydrochloride
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

nicardipine hydrochloride 25 mg/10mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1482
Product ID 51662-1482_2b39b839-0c80-de03-e063-6294a90a243e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022276
Listing Expiration 2026-12-31
Marketing Start 2020-02-01

Pharmacologic Class

Classes
calcium channel antagonists [moa] cytochrome p450 2c19 inhibitors [moa] cytochrome p450 2c8 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] dihydropyridine calcium channel blocker [epc] dihydropyridines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621482
Hyphenated Format 51662-1482

Supplemental Identifiers

RxCUI
858607
UNII
K5BC5011K3

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nicardipine hydrochloride (source: ndc)
Generic Name nicardipine hydrochloride (source: ndc)
Application Number NDA022276 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 25 mg/10mL
source: ndc
Packaging
  • 10 mL in 1 VIAL (51662-1482-1)
source: ndc

Packages (1)

51662-1482-1 10 mL in 1 VIAL (51662-1482-1)

Ingredients (1)

nicardipine hydrochloride (25 mg/10mL)

Linked Drug Pages (1)

NICARDIPINE HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2b39b839-0c80-de03-e063-6294a90a243e", "openfda": {"unii": ["K5BC5011K3"], "rxcui": ["858607"], "spl_set_id": ["9d898911-d811-2a78-e053-2995a90af784"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "10 mL in 1 VIAL (51662-1482-1)", "package_ndc": "51662-1482-1", "marketing_start_date": "20200201"}], "brand_name": "NICARDIPINE HYDROCHLORIDE", "product_id": "51662-1482_2b39b839-0c80-de03-e063-6294a90a243e", "dosage_form": "INJECTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "51662-1482", "generic_name": "NICARDIPINE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NICARDIPINE HYDROCHLORIDE", "active_ingredients": [{"name": "NICARDIPINE HYDROCHLORIDE", "strength": "25 mg/10mL"}], "application_number": "NDA022276", "marketing_category": "NDA", "marketing_start_date": "20200201", "listing_expiration_date": "20261231"}